| Dr Andre Plair, MD | |
|
Stony Brook University Medical Ctr, Department Of Ob/gyn, Hsc, T9, Stony Brook, NY 11794-8091 | |
| (631) 444-4686 | |
| (631) 444-4622 |
| Full Name | Dr Andre Plair |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | Stony Brook University Medical Ctr, Stony Brook, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093158081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2017-01861 (North Carolina) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 305582-01 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Associates In Obstetrics And Gynecology University Faculty | 9032001045 | 93 |
News Archive
MonaVie, maker of premier acai-based nutritional and energy drink products, today announces that the lawsuit brought against it and other defendants by Harpo Inc., owner of the Oprah Winfrey family of trademarks, and Dr. Mehmet Oz, a doctor who regularly appeared on The Oprah Winfrey Show and now host of "The Dr. Oz Show," for the unauthorized use of their names and images, has been amicably resolved.
Cancer cells need life-essential molecules to proliferate. These so-called growth factors are activated by ectodomain shedding of precursor proteins on the outside of the plasma membrane, mainly carried out by three human cleavage enzymes. A pharmaceutical blocking of these enzymes could hinder cancer from growing but would also inhibit other life-essential processes.
Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.
Every day, our gut comes in contact with bacteria, inducing an inflammatory response that is tolerated and controlled. Sometimes the control of inflammation is lost and this can lead to inflammatory bowel disease that may predispose to colon cancer.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
› Verified 1 days ago
| Entity Name | University Associates In Obstetrics & Gynecology University Faculty P |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538114723 PECOS PAC ID: 9032001045 Enrollment ID: O20040325001243 |
News Archive
MonaVie, maker of premier acai-based nutritional and energy drink products, today announces that the lawsuit brought against it and other defendants by Harpo Inc., owner of the Oprah Winfrey family of trademarks, and Dr. Mehmet Oz, a doctor who regularly appeared on The Oprah Winfrey Show and now host of "The Dr. Oz Show," for the unauthorized use of their names and images, has been amicably resolved.
Cancer cells need life-essential molecules to proliferate. These so-called growth factors are activated by ectodomain shedding of precursor proteins on the outside of the plasma membrane, mainly carried out by three human cleavage enzymes. A pharmaceutical blocking of these enzymes could hinder cancer from growing but would also inhibit other life-essential processes.
Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.
Every day, our gut comes in contact with bacteria, inducing an inflammatory response that is tolerated and controlled. Sometimes the control of inflammation is lost and this can lead to inflammatory bowel disease that may predispose to colon cancer.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andre Plair, MD Po Box 1559, Stony Brook, NY 11790-0989 Ph: (631) 444-3987 | Dr Andre Plair, MD Stony Brook University Medical Ctr, Department Of Ob/gyn, Hsc, T9, Stony Brook, NY 11794-8091 Ph: (631) 444-4686 |
News Archive
MonaVie, maker of premier acai-based nutritional and energy drink products, today announces that the lawsuit brought against it and other defendants by Harpo Inc., owner of the Oprah Winfrey family of trademarks, and Dr. Mehmet Oz, a doctor who regularly appeared on The Oprah Winfrey Show and now host of "The Dr. Oz Show," for the unauthorized use of their names and images, has been amicably resolved.
Cancer cells need life-essential molecules to proliferate. These so-called growth factors are activated by ectodomain shedding of precursor proteins on the outside of the plasma membrane, mainly carried out by three human cleavage enzymes. A pharmaceutical blocking of these enzymes could hinder cancer from growing but would also inhibit other life-essential processes.
Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.
Every day, our gut comes in contact with bacteria, inducing an inflammatory response that is tolerated and controlled. Sometimes the control of inflammation is lost and this can lead to inflammatory bowel disease that may predispose to colon cancer.
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.
› Verified 1 days ago
Noel Omar Mohammed, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Rd., Stony Brook University Student Health Service, Stony Brook, NY 11790 Phone: 631-632-6740 | |
Dr. Michael L. Pearl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Hsc 9th Fl. Rm 065, Stony Brook University Hospital, Stony Brook, NY 11790 Phone: 631-444-6907 | |
Scott Berman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 Nesconset Hwy, Building 12 Suite 45, Stony Brook, NY 11790 Phone: 631-675-9010 Fax: 631-675-9009 | |
Dr. Christian P Westermann, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2500 Route 347, Building 19c, Suite 72, Stony Brook, NY 11790 Phone: 631-751-9700 Fax: 631-751-6979 | |
Nicole Lynn Massad, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Dr. Diana Calero-kunda, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Road Hsc Level 9 Rm 090, Stony Brook, NY 11794 Phone: 631-444-2757 Fax: 631-444-6155 |